Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 2/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 8/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.34 |
| ▸ | HINT1 | P49773 | 1/20 | 0.33 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.32 |
| ▸ | TRDMT1 | O14717 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL259872 | 0.86 | TYMP (0.31) | TYMP | |
| SCHEMBL29657013 | 0.79 | TYMP (0.46) | TYMPADORA1 | |
| SCHEMBL17599828 | 0.75 | TYMP (0.49) | TYMPHINT1 | |
| SCHEMBL6831440 | 0.74 | TYMP (0.48) | TYMPHINT1 | |
| SCHEMBL7647098 | 0.72 | TAAR1 (0.47) | TYMPHINT1 | |
| SCHEMBL16401878 | 0.71 | TYMP (0.49) | TYMPHINT1 | |
| SCHEMBL30002219 | 0.71 | TYMP (0.56) | TYMPADORA1HINT1 | |
| SCHEMBL10446715 | 0.70 | TYMP (0.44) | TYMPHINT1 | |
| SCHEMBL313747 | 0.70 | TYMP (0.62) | TYMPHINT1 | |
| SCHEMBL313746 | 0.70 | TYMP (0.62) | TYMPHINT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2057284-A1 | COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS | Isis Pharmaceuticals, Inc. (US) | 2009-05-13 | — | — | EP | disclosed |
| WO-2008017081-A1 | COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS | ISIS PHARMACEUTICALS, INC. (US) | 2008-02-07 | — | — | WO | disclosed |
| EP-1572713-A2 | ANTISENSE MODULATION OF ACYL-COA SYNTHETASE 1 EXPRESSION | Pharmacia Corporation (US) | 2005-09-14 | — | — | EP | disclosed |
| EP-1567538-A2 | ANTISENSE MODULATION OF GFAT EXPRESSION | Pharmacia Corporation (US) | 2005-08-31 | — | — | EP | disclosed |
| EP-1556509-A2 | ANTISENSE MODULATION OF VEGF CO-REGULATED CHEMOKINE-1 EXPRESSION | Pharmacia Corporation (US) | 2005-07-27 | — | — | EP | disclosed |
| EP-1543159-A2 | ANTISENSE MODULATION OF ENDOTHELIAL SPECIFIC MOLECULE 1 EXPRESSION | Pharmacia Corporation (US) | 2005-06-22 | — | — | EP | disclosed |
| WO-2004035763-A2 | ANTISENSE MODULATION OF GFAT EXPRESSION | PHARMACIA CORPORATION (US) | 2004-04-29 | — | — | WO | disclosed |
| WO-2004021978-A2 | ANTISENSE MODULATION OF ENDOTHELIAL SPECIFIC MOLECULE 1 EXPRESSION | PHARMACIA CORPORATION (US) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004016749-A2 | ANTISENSE MODULATION OF ACYL-COA SYNTHETASE 1 EXPRESSION | PHARMACIA CORPORATION (US) | 2004-02-26 | — | — | WO | disclosed |
| WO-2004016224-A2 | ANTISENSE MODULATION OF VEGF CO-REGULATED CHEMOKINE-1 EXPRESSION | PHARMACIA CORPORATION (US) | 2004-02-26 | — | — | WO | disclosed |
| US-20040014050-A1 | Antisense modulation of EDG8 expression | ISIS PHARMACEUTICALS INC. | 2004-01-22 | — | — | US | disclosed |
| WO-2004005554-A2 | ANTISENSE MODULATION OF LIVIN EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2004-01-15 | — | — | WO | disclosed |